[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351652-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351652-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","non-ocular-cancers-in-parents-of-patients-diagnosed-with-retinoblastoma-in-britain-1949-to-1987","Non-Ocular Cancers in Parents of Patients Diagnosed with Retinoblastoma in Britain - 1949 to 1987","","Mutations in the retinoblastoma gene (RB1) are linked to retinoblastoma and other cancers. Parents of children with retinoblastoma can be grouped by the likelihood of carrying a germline RB1 mutation. A cohort of 1180 such parents was followed for incident cancer using national records, and Standardised Incidence Ratios (SIRs) were computed for all non-ocular cancers and diagnostic categories. Fathers and mothers with retinoblastoma showed significantly increased risks, while non-affected mutation carriers had a lower, non-significant increase; pooled lifetime estimates supported a markedly higher risk for mutation carriers after the birth of the affected child. Non-carriers had risks similar to the general population.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/non-ocular-cancers-in-parents-of-patients-diagnosed-with-retinoblastoma-in-britain-1949-to-1987/351652/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/non-ocular-cancers-in-parents-of-patients-diagnosed-with-retinoblastoma-in-britain-1949-to-1987/351652.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were parents classified in this study?","Question",{"text":63,"@type":64},"Parents were grouped according to the likelihood that they carried an RB1 germline mutation, including categories such as known carriers and possible carriers versus probable non-carriers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What cancer risk did parents with retinoblastoma have?",{"text":68,"@type":64},"Fathers and mothers who themselves had retinoblastoma showed significantly higher risk of non-ocular cancer than the general population, with SIRs of 3.56 for fathers and 3.25 for mothers.",{"name":70,"@type":61,"acceptedAnswer":71},"How did mutation carriers compare with non-carriers regarding lifetime risk?",{"text":72,"@type":64},"When pooled with results from an earlier study, mutation-carrier parents had an estimated fourfold higher lifetime SIR for non-ocular cancer after the birth of their affected child, whereas parents not carrying the mutation had a risk similar to the general population.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351652,1790147890,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nNon-Ocular Cancers in Parents of Patients Diagnosed with Retinoblastoma in Britain 1949 to 1987  \nCharles A. Stiller 1,2, *, Angela MacCarthy 2, Kathryn J. Bunch 2, Nicole L. Diggens 2,3, Gerald J. Draper 2 and Michael F. G. Murphy 2,4  \nAcademic Editor: Dominik  \nT. Schneider  \nReceived: 13 March 2026  \nRevised: 8 April 2026  \nAccepted: 10 April 2026  \nPublished: 28 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 National Disease Registration Service, NHS England, London SE1 8UG, UK  \n2 Formerly with Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, Oxford OX1 2JD, UK  \n3 UConn Center on Aging, University of Connecticut Health Center, Farmington Ave., Farmington, CT 06030, USA  \n4 Nuffield Department of Women’s and Reproductive Health, University of Oxford, Women’s Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK  \n* Correspondence: [charles.stiller1@nhs.net](charles.stiller1@nhs.net)  \nSimple Summary  \nMutations in the retinoblastoma gene (RB1) are associated with risks of retinoblastoma and other cancers. Parents of children with retinoblastoma can be categorised according to their likelihood of carrying a germline RB1 mutation. To obtain reliable estimates of cancer risk to parents of a child with retinoblastoma after the birth of such a child, we studied a cohort of 1180 such parents. Fathers and mothers who themselves had retinoblastoma each had a threefold higher risk of non-ocular cancer than the general population. The very small group of parents known to be carrying a germline RB1 mutation but not affected by retinoblastoma had a lower, but non-significant, increase in risk. When our results were pooled with those for largely the same group of parents at younger ages, those known tobe mutation carriers had an estimated fourfold higher lifetime risk of non-ocular cancer after the birth of their affected child. Parents who are not mutation carriers have a cancer risk similar to the general population.  \nAbstract  \nBackground: Mutations in the retinoblastoma gene (RB1) are associated with risks of both retinoblastoma and other cancers. Parents of children with retinoblastoma can be categorised according to their likelihood of carrying a germline RB1 mutation. Some categories of such parents may have an increased risk of cancer. Methods: A cohort of 1180 parents of children with retinoblastoma were categorised according to the likelihood that they carried an RB1 mutation and followed up for cancer through national records. We calculated Standardised Incidence Ratios (SIRs) for all non-ocular cancers combined and for individual diagnostic groups, with expected numbers derived from national cancer registration rates. Finally, we pooled the all-cancers results from the present study with those from an earlier study of largely the same cohort with non-overlapping follow-up. Results: In total, 183 non-ocular cancers were identified among the parents. Parents who themselves had retinoblastoma had a significantly higher risk of non-ocular cancer than the general population: for fathers, the SIR was 3.56 (95% confidence interval (CI) 1.84–6.22); formothers, it was 3.25 (1.49–6.18) . For the very small group of parents known to be carrying a germline RB1 mutation but not affected by retinoblastoma, there was a lower and nonsignificant increase in risk (SIR = 1.9) . Parents categorised as either possible carriers or probable non-carriers had similar observed risks to the general population. When the allcancers results were pooled with those from an earlier study of very largely the same cohort  \nwith non-overlapping follow-up, the estimated lifetime SIR for non-ocular cancer among mutation-carrier parents after the birth of their affected child was 4.32 (95% CI 3.06–5.93) . Conclusions: Our results confirm that paren","cbCaikjyHVk4BDXx","https://ap.wps.com/l/cbCaikjyHVk4BDXx","pdf",234024,12,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How were parents classified in this study?\",\"answer\":\"Parents were grouped according to the likelihood that they carried an RB1 germline mutation, including categories such as known carriers and possible carriers versus probable non-carriers.\"},{\"question\":\"What cancer risk did parents with retinoblastoma have?\",\"answer\":\"Fathers and mothers who themselves had retinoblastoma showed significantly higher risk of non-ocular cancer than the general population, with SIRs of 3.56 for fathers and 3.25 for mothers.\"},{\"question\":\"How did mutation carriers compare with non-carriers regarding lifetime risk?\",\"answer\":\"When pooled with results from an earlier study, mutation-carrier parents had an estimated fourfold higher lifetime SIR for non-ocular cancer after the birth of their affected child, whereas parents not carrying the mutation had a risk similar to the general population.\"}]","Non-Ocular Cancers in Parents of Patients Diagnosed with Retinoblastoma in Britain - 1949 to 1987 | PDF",1790095128,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06906d248514d717fb94aec7e3d91876.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4116df20a736a952fa585d336b3910b.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e13153d1fe288e40ea12d44779853344.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34004bc4a9088ac1d209e1ce0b1ab03a.webp",980,1385]